Quince Therapeutics Announces Frontiers in Neurology Publication of Long-Term Safety of EryDex in Pediatric Patients with Ataxia-Telangiectasia
Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s ...
Optimistic Outlook on Larimar Therapeutics’ Nomlabofusp: Advancements in Clinical Trials for Adolescents with Friedreich’s Ataxia
Leerink Partners analyst Joseph Schwartz has reiterated their bullish stance on LRMR stock, giving a Buy rating on January 24.Invest with ...
Le Lézard1h
Norlase Receives FDA 510(k) Clearance and CE Mark for LYNXtm Pattern Scanning Laser Indirect Ophthalmoscope
Norlase, a leading global ophthalmic laser manufacturer developing next-generation laser solutions, today announced the ...
Le Lézard1h
RELEX Solutions Secures ?10 Million Green Revolving Credit Facility
RELEX Solutions, a provider of unified supply chain and retail planning solutions, today announced it has secured a ?10 million green revolving credit facility that can be used to finance projects and ...
H.C. Wainwright maintains $30 target on Voyager Therapeutics stock
The confidence in Voyager Therapeutics (NASDAQ:VYGR)' stock is further supported by the company's strategic collaborations, ...
Larimar Therapeutics’ (LRMR) Buy Rating Reiterated at HC Wainwright
HC Wainwright reissued their buy rating on shares of Larimar Therapeutics (NASDAQ:LRMR – Free Report) in a report issued on Friday morning,Benzinga reports. HC Wainwright currently has a $15.00 target ...
Mamamia on MSN13h
Sue thought she had a pinched nerve in her back. The reality was far worse.
Sue loves to run. In fact, it's exactly what she was doing when she realised something was wrong."I started to get really ...
News 12 Networks1h
Kane in Your Corner: FDA warns of adverse effects, including death, from dog arthritis drug Librela
The U.S. Food and Drug Administration is raising alarms about Librela, warning veterinarians of potential adverse effects, ...